Status:
COMPLETED
Trochanteric Hip Fractures (AO A2) SHS With or Without Trochanteric Stabilizing Plate - Rct Using RSA
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
Diakonhjemmet Hospital
Conditions:
Hip Fractures
Trochanteric Fractures
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Trochanteric fractures represent about half of the hip fractures (with femoral neck fractures as the other half). Trochanteric hip fractures are almost always treated surgically with internal fixation...
Detailed Description
Trochanteric fractures represent about half of the hip fractures (with femoral neck fractures as the other half), and are almost always treated surgically with internal fixation of the fracture. Howev...
Eligibility Criteria
Inclusion
- AO 31-A2
- able to walk independently, aids such as crutches or walker allowed
- able to consent
- fit for surgery with SHS with or without TSP
Exclusion
- not willing or able to attain follow up
- previous fracture or surgery with retained metal work in the same hip
- concomitant disease that will shorten life expectancy
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT02294747
Start Date
November 1 2014
End Date
December 1 2018
Last Update
September 29 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Orthopedic Center, Ulleval University Hospital
Oslo, Norway, 0408
2
Diakonhjemmet Hospital
Oslo, Norway